PeptidesInfo

Research area

How to interpret studies

Most misleading peptide claims cite real studies. The trick is in what the study was — a rat model, a cell culture, an uncontrolled case series — and what it measured. This hub collects our explainers on reading research critically.

Abstract illustration of a peptide chain used as the how to interpret studies hub image

The five questions to ask of any peptide study

  1. Who or what was studied? Humans, animals, or cells. Then: how many, how old, how healthy, and how similar to you.
  2. Was there a control group, and was allocation random and blinded? Uncontrolled studies cannot separate the treatment from time, placebo effects and regression to the mean.
  3. What was the primary outcome, and was it prespecified? A study that measures twenty things and reports the three that moved is not evidence.
  4. How big was the effect, with what uncertainty? "Statistically significant" can describe a trivial change; look for confidence intervals and absolute differences.
  5. Who paid, and has anyone replicated it? Industry funding does not invalidate a result but raises the bar for independent confirmation.

The animal-to-human gap

Rodent studies are essential for mechanism and early safety, but their translation rate to human efficacy is poor across medicine — and worse for regenerative and neurological outcomes than for, say, antibiotics. Animal models are young, genetically uniform, and injured deliberately in ways that rarely match human disease. When a peptide's evidence is entirely animal, the honest statement is "we do not know whether this works in people".

How marketing misuses real papers

  • Citing a rat study under a headline about human healing.
  • Quoting a mechanism ("increases growth hormone") as if it were an outcome ("builds muscle").
  • Presenting a case report or a single open-label study as proof.
  • Describing decades of publications from one lab as a "large body of evidence".
  • Conflating "not FDA-approved" with "FDA hasn't gotten around to it" rather than "no adequate trials exist".

Our explainers linked below go through each of these with worked examples from the peptide literature.

Analyses in how to interpret studies

Benefits4 min read

Peptides for Hair Growth: What Has Actually Been Tested

Copper peptides and biotinoyl tripeptide-1 are sold widely for hair loss. The supporting studies are mostly cells and animals. Here is what exists in humans, and how it compares with the two treatments that have decades of trial data.

Benefits4 min read

Peptides for Energy and Sleep: Claims Versus Trials

Better sleep and more energy are standard peptide selling points. No growth-hormone secretagogue has been tested with sleep laboratory measurement, and the one peptide with a large sleep trial works by a completely different route.

Benefits4 min read

Copper Peptides vs Retinoids: Comparing the Skin Evidence

Copper peptides and topical retinoids are both sold for photoaged skin. One has several small trials, the other decades of large ones. What each has actually demonstrated, and the head-to-head trial nobody has run.

Foundations4 min read

FDA-Approved vs Proven Effective: Why They Are Not the Same

"FDA-approved" and "works" are different questions, and conflating them is how most peptide confusion starts. This explains the two independent axes — regulatory status and evidence level — with four worked examples.

Benefits4 min read

Peptides for Muscle Growth: What the Evidence Supports

Growth-hormone peptides are sold almost entirely on muscle claims. No controlled trial has measured muscle with them. The one peptide with positive lean-mass data is the one nobody markets for it.

Benefits4 min read

Are Peptides Worth It? A Framework for Deciding

Whether a peptide is worth it depends on four things: what benefit is proven, in whom, for how long, and whether the effect lasts after you stop. Here is that framework applied to every peptide we cover.

Benefits4 min read

Peptides for Skin: The Benefits With Human Trials Behind Them

Skin is one of the few areas where peptides have real human trials. Topical copper peptides and oral collagen both improve measurable skin properties — modestly, over weeks, in studies mostly funded by the people selling them.

Benefits5 min read

Peptides for Recovery: Which Benefits Are Actually Documented

Recovery is the most-marketed peptide benefit and the least proven. This separates the recovery claims with human trials behind them from the ones resting entirely on rodent studies — and names what would change the verdict.

Benefits8 min read

Peptide Benefits: What the Evidence Actually Supports

Peptides are credited with dozens of benefits. Some are proven in large trials, some are modest and real, and some have never been tested in a person. This is every major benefit claim, sorted by how strong the human evidence is.

Research analysis6 min read

BPC-157: Human Evidence, Animal Research, and Open Questions

BPC-157 has hundreds of positive animal studies and almost no controlled human data. We separate what the rat research shows, what the few human reports show, what the FDA has said, and what would have to happen for the evidence grade to change.

Safety5 min read

Peptide Purity, Contamination, and the Limits of a Certificate of Analysis

A certificate of analysis is the main reassurance offered by 'research peptide' vendors. Here is what a CoA can and cannot tell you — identity, purity, quantity, sterility, endotoxin — why '99% pure' is not what it sounds like, and what independent testing of grey-market peptides has found.

Foundations5 min read

How to Read Peptide Research Without Falling for Marketing

Most misleading peptide claims cite real studies. This guide shows how to tell a rat model from a human trial, a mechanism from an outcome, and a case report from evidence — with worked examples from BPC-157, growth hormone secretagogues and collagen research.

Foundations4 min read

What Are Peptides? A Research-Based Introduction

Peptides are short chains of amino acids that range from approved blockbuster drugs to unregulated 'research chemicals'. Here is what the word actually covers, how peptides differ from proteins and small-molecule drugs, and why the category tells you nothing about evidence.